SOD1 and pulmonary arterial hypertension: Together these data suggest that, despite protective effects of TEMPOL in limiting vasoconstrictor reactivity and the increase in RVSP, the exacerbation of arterial remodeling may pose therapeutic limitations of using an SOD mimetic in severe PAH.